Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative bacteria

Infections caused by Gram-negative bacteria, Escherichia coli and Pseudomonas aeruginosa foremost among them, constitute a major worldwide health problem. Bioinformatics methodologies are being used to rationally design new antimicrobial peptides, a potential alternative for treating these infection...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochimica et biophysica acta. Biomembranes 2019-07, Vol.1861 (7), p.1375-1387
Hauptverfasser: Fensterseifer, Isabel C.M., Felício, Mário R., Alves, Eliane S.F., Cardoso, Marlon H., Torres, Marcelo D.T., Matos, Carolina O., Silva, Osmar N., Lu, Timothy K., Freire, Maurício V., Neves, Natan C., Gonçalves, Sónia, Lião, Luciano M., Santos, Nuno C., Porto, William F., de la Fuente-Nunez, Cesar, Franco, Octavio L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1387
container_issue 7
container_start_page 1375
container_title Biochimica et biophysica acta. Biomembranes
container_volume 1861
creator Fensterseifer, Isabel C.M.
Felício, Mário R.
Alves, Eliane S.F.
Cardoso, Marlon H.
Torres, Marcelo D.T.
Matos, Carolina O.
Silva, Osmar N.
Lu, Timothy K.
Freire, Maurício V.
Neves, Natan C.
Gonçalves, Sónia
Lião, Luciano M.
Santos, Nuno C.
Porto, William F.
de la Fuente-Nunez, Cesar
Franco, Octavio L.
description Infections caused by Gram-negative bacteria, Escherichia coli and Pseudomonas aeruginosa foremost among them, constitute a major worldwide health problem. Bioinformatics methodologies are being used to rationally design new antimicrobial peptides, a potential alternative for treating these infections. One of the algorithms used to develop antimicrobial peptides is the Joker, which was used to design the peptide PaDBS1R6. This study evaluates the antibacterial activities of PaDBS1R6 in vitro and in vivo, characterizes the peptide interaction to target membranes, and investigates the PaDBS1R6 structure in contact with mimetic vesicles. Moreover, we demonstrate that PaDBS1R6 exhibits selective antimicrobial activity against Gram-negative bacteria. In the presence of negatively charged and zwitterionic lipids the structural arrangement of PaDBS1R6 transits from random coil to α-helix, as characterized by circular dichroism. The tertiary structure of PaDBS1R6 was determined by NMR in zwitterionic dodecylphosphocholine (DPC) micelles. In conclusion, PaDBS1R6 is a candidate for the treatment of nosocomial infections caused by Gram-negative bacteria, as template for producing other antimicrobial agents. [Display omitted] •PaDBS1R6 presented in-helix conformation when in contact with anionic lipid membranes•Antibacterial selectivity of PaDBS1R6 against Gram-negative bacteria•PaDBS1R6 was active in vivo in murine intraperitoneal and skin infection models.
doi_str_mv 10.1016/j.bbamem.2019.03.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2200809465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0005273619300744</els_id><sourcerecordid>2200809465</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-f54be4f103f245547058dab37c885545554a127f1823f084267c9f3fa479e3633</originalsourceid><addsrcrecordid>eNp9kU1rFTEUhoMo9lr9ByLjzs2M-Z7MRtCqVSgoVtfxTOak5jJfJrkX-u_NdVqXLkLIy3PehCeEPGe0YZTp1_um72HCqeGUdQ0VTQkfkB0zbVdzLflDsqOUqpq3Qp-RJyntaSEkV4_JmaAd10KrHfl5jSO6HI5YwZxDDy5jDDBWcApDvq0WX-VfWDnIYZmDq1Zccxiw-grv312zb7qCGwhzytVlhKme8Qb-tt03PSWPPIwJn93t5-THxw_fLz7VV18uP1-8vaqdMCbXXskepWdUeC6Vki1VZoBetM6YclRlAeOtZ4YLT43kunWdFx5k26HQQpyTV1vvGpffB0zZTiE5HEeYcTkkyzmlhnZSq4LKDXVxSSmit2sME8Rby6g9ubV7u7m1J7eWClvCMvbi7oZDP-Hwb-heZgFebkB0AKuNeAwpQyqVUjGreKdMYd5sDBYXx4DRJhdwdjiEWP7BDkv4_yv-AF_7la8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2200809465</pqid></control><display><type>article</type><title>Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative bacteria</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Fensterseifer, Isabel C.M. ; Felício, Mário R. ; Alves, Eliane S.F. ; Cardoso, Marlon H. ; Torres, Marcelo D.T. ; Matos, Carolina O. ; Silva, Osmar N. ; Lu, Timothy K. ; Freire, Maurício V. ; Neves, Natan C. ; Gonçalves, Sónia ; Lião, Luciano M. ; Santos, Nuno C. ; Porto, William F. ; de la Fuente-Nunez, Cesar ; Franco, Octavio L.</creator><creatorcontrib>Fensterseifer, Isabel C.M. ; Felício, Mário R. ; Alves, Eliane S.F. ; Cardoso, Marlon H. ; Torres, Marcelo D.T. ; Matos, Carolina O. ; Silva, Osmar N. ; Lu, Timothy K. ; Freire, Maurício V. ; Neves, Natan C. ; Gonçalves, Sónia ; Lião, Luciano M. ; Santos, Nuno C. ; Porto, William F. ; de la Fuente-Nunez, Cesar ; Franco, Octavio L.</creatorcontrib><description>Infections caused by Gram-negative bacteria, Escherichia coli and Pseudomonas aeruginosa foremost among them, constitute a major worldwide health problem. Bioinformatics methodologies are being used to rationally design new antimicrobial peptides, a potential alternative for treating these infections. One of the algorithms used to develop antimicrobial peptides is the Joker, which was used to design the peptide PaDBS1R6. This study evaluates the antibacterial activities of PaDBS1R6 in vitro and in vivo, characterizes the peptide interaction to target membranes, and investigates the PaDBS1R6 structure in contact with mimetic vesicles. Moreover, we demonstrate that PaDBS1R6 exhibits selective antimicrobial activity against Gram-negative bacteria. In the presence of negatively charged and zwitterionic lipids the structural arrangement of PaDBS1R6 transits from random coil to α-helix, as characterized by circular dichroism. The tertiary structure of PaDBS1R6 was determined by NMR in zwitterionic dodecylphosphocholine (DPC) micelles. In conclusion, PaDBS1R6 is a candidate for the treatment of nosocomial infections caused by Gram-negative bacteria, as template for producing other antimicrobial agents. [Display omitted] •PaDBS1R6 presented in-helix conformation when in contact with anionic lipid membranes•Antibacterial selectivity of PaDBS1R6 against Gram-negative bacteria•PaDBS1R6 was active in vivo in murine intraperitoneal and skin infection models.</description><identifier>ISSN: 0005-2736</identifier><identifier>EISSN: 1879-2642</identifier><identifier>DOI: 10.1016/j.bbamem.2019.03.016</identifier><identifier>PMID: 30926365</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Anti-Bacterial Agents - pharmacology ; Antibiotic resistance ; Antimicrobial Cationic Peptides - pharmacology ; Antimicrobial peptide (AMP) ; Drug design ; Escherichia coli ; Gram-Negative Bacteria - drug effects ; Joker algorithm ; Mice ; Mice, Inbred C57BL ; Microbial Sensitivity Tests ; PaDBS1R6 ; Pseudomonas aeruginosa</subject><ispartof>Biochimica et biophysica acta. Biomembranes, 2019-07, Vol.1861 (7), p.1375-1387</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-f54be4f103f245547058dab37c885545554a127f1823f084267c9f3fa479e3633</citedby><cites>FETCH-LOGICAL-c388t-f54be4f103f245547058dab37c885545554a127f1823f084267c9f3fa479e3633</cites><orcidid>0000-0002-0580-0475 ; 0000-0002-9398-2140 ; 0000-0003-2903-4282</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0005273619300744$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30926365$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fensterseifer, Isabel C.M.</creatorcontrib><creatorcontrib>Felício, Mário R.</creatorcontrib><creatorcontrib>Alves, Eliane S.F.</creatorcontrib><creatorcontrib>Cardoso, Marlon H.</creatorcontrib><creatorcontrib>Torres, Marcelo D.T.</creatorcontrib><creatorcontrib>Matos, Carolina O.</creatorcontrib><creatorcontrib>Silva, Osmar N.</creatorcontrib><creatorcontrib>Lu, Timothy K.</creatorcontrib><creatorcontrib>Freire, Maurício V.</creatorcontrib><creatorcontrib>Neves, Natan C.</creatorcontrib><creatorcontrib>Gonçalves, Sónia</creatorcontrib><creatorcontrib>Lião, Luciano M.</creatorcontrib><creatorcontrib>Santos, Nuno C.</creatorcontrib><creatorcontrib>Porto, William F.</creatorcontrib><creatorcontrib>de la Fuente-Nunez, Cesar</creatorcontrib><creatorcontrib>Franco, Octavio L.</creatorcontrib><title>Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative bacteria</title><title>Biochimica et biophysica acta. Biomembranes</title><addtitle>Biochim Biophys Acta Biomembr</addtitle><description>Infections caused by Gram-negative bacteria, Escherichia coli and Pseudomonas aeruginosa foremost among them, constitute a major worldwide health problem. Bioinformatics methodologies are being used to rationally design new antimicrobial peptides, a potential alternative for treating these infections. One of the algorithms used to develop antimicrobial peptides is the Joker, which was used to design the peptide PaDBS1R6. This study evaluates the antibacterial activities of PaDBS1R6 in vitro and in vivo, characterizes the peptide interaction to target membranes, and investigates the PaDBS1R6 structure in contact with mimetic vesicles. Moreover, we demonstrate that PaDBS1R6 exhibits selective antimicrobial activity against Gram-negative bacteria. In the presence of negatively charged and zwitterionic lipids the structural arrangement of PaDBS1R6 transits from random coil to α-helix, as characterized by circular dichroism. The tertiary structure of PaDBS1R6 was determined by NMR in zwitterionic dodecylphosphocholine (DPC) micelles. In conclusion, PaDBS1R6 is a candidate for the treatment of nosocomial infections caused by Gram-negative bacteria, as template for producing other antimicrobial agents. [Display omitted] •PaDBS1R6 presented in-helix conformation when in contact with anionic lipid membranes•Antibacterial selectivity of PaDBS1R6 against Gram-negative bacteria•PaDBS1R6 was active in vivo in murine intraperitoneal and skin infection models.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotic resistance</subject><subject>Antimicrobial Cationic Peptides - pharmacology</subject><subject>Antimicrobial peptide (AMP)</subject><subject>Drug design</subject><subject>Escherichia coli</subject><subject>Gram-Negative Bacteria - drug effects</subject><subject>Joker algorithm</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Microbial Sensitivity Tests</subject><subject>PaDBS1R6</subject><subject>Pseudomonas aeruginosa</subject><issn>0005-2736</issn><issn>1879-2642</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1rFTEUhoMo9lr9ByLjzs2M-Z7MRtCqVSgoVtfxTOak5jJfJrkX-u_NdVqXLkLIy3PehCeEPGe0YZTp1_um72HCqeGUdQ0VTQkfkB0zbVdzLflDsqOUqpq3Qp-RJyntaSEkV4_JmaAd10KrHfl5jSO6HI5YwZxDDy5jDDBWcApDvq0WX-VfWDnIYZmDq1Zccxiw-grv312zb7qCGwhzytVlhKme8Qb-tt03PSWPPIwJn93t5-THxw_fLz7VV18uP1-8vaqdMCbXXskepWdUeC6Vki1VZoBetM6YclRlAeOtZ4YLT43kunWdFx5k26HQQpyTV1vvGpffB0zZTiE5HEeYcTkkyzmlhnZSq4LKDXVxSSmit2sME8Rby6g9ubV7u7m1J7eWClvCMvbi7oZDP-Hwb-heZgFebkB0AKuNeAwpQyqVUjGreKdMYd5sDBYXx4DRJhdwdjiEWP7BDkv4_yv-AF_7la8</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Fensterseifer, Isabel C.M.</creator><creator>Felício, Mário R.</creator><creator>Alves, Eliane S.F.</creator><creator>Cardoso, Marlon H.</creator><creator>Torres, Marcelo D.T.</creator><creator>Matos, Carolina O.</creator><creator>Silva, Osmar N.</creator><creator>Lu, Timothy K.</creator><creator>Freire, Maurício V.</creator><creator>Neves, Natan C.</creator><creator>Gonçalves, Sónia</creator><creator>Lião, Luciano M.</creator><creator>Santos, Nuno C.</creator><creator>Porto, William F.</creator><creator>de la Fuente-Nunez, Cesar</creator><creator>Franco, Octavio L.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>RCLKO</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0580-0475</orcidid><orcidid>https://orcid.org/0000-0002-9398-2140</orcidid><orcidid>https://orcid.org/0000-0003-2903-4282</orcidid></search><sort><creationdate>20190701</creationdate><title>Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative bacteria</title><author>Fensterseifer, Isabel C.M. ; Felício, Mário R. ; Alves, Eliane S.F. ; Cardoso, Marlon H. ; Torres, Marcelo D.T. ; Matos, Carolina O. ; Silva, Osmar N. ; Lu, Timothy K. ; Freire, Maurício V. ; Neves, Natan C. ; Gonçalves, Sónia ; Lião, Luciano M. ; Santos, Nuno C. ; Porto, William F. ; de la Fuente-Nunez, Cesar ; Franco, Octavio L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-f54be4f103f245547058dab37c885545554a127f1823f084267c9f3fa479e3633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotic resistance</topic><topic>Antimicrobial Cationic Peptides - pharmacology</topic><topic>Antimicrobial peptide (AMP)</topic><topic>Drug design</topic><topic>Escherichia coli</topic><topic>Gram-Negative Bacteria - drug effects</topic><topic>Joker algorithm</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Microbial Sensitivity Tests</topic><topic>PaDBS1R6</topic><topic>Pseudomonas aeruginosa</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fensterseifer, Isabel C.M.</creatorcontrib><creatorcontrib>Felício, Mário R.</creatorcontrib><creatorcontrib>Alves, Eliane S.F.</creatorcontrib><creatorcontrib>Cardoso, Marlon H.</creatorcontrib><creatorcontrib>Torres, Marcelo D.T.</creatorcontrib><creatorcontrib>Matos, Carolina O.</creatorcontrib><creatorcontrib>Silva, Osmar N.</creatorcontrib><creatorcontrib>Lu, Timothy K.</creatorcontrib><creatorcontrib>Freire, Maurício V.</creatorcontrib><creatorcontrib>Neves, Natan C.</creatorcontrib><creatorcontrib>Gonçalves, Sónia</creatorcontrib><creatorcontrib>Lião, Luciano M.</creatorcontrib><creatorcontrib>Santos, Nuno C.</creatorcontrib><creatorcontrib>Porto, William F.</creatorcontrib><creatorcontrib>de la Fuente-Nunez, Cesar</creatorcontrib><creatorcontrib>Franco, Octavio L.</creatorcontrib><collection>RCAAP open access repository</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochimica et biophysica acta. Biomembranes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fensterseifer, Isabel C.M.</au><au>Felício, Mário R.</au><au>Alves, Eliane S.F.</au><au>Cardoso, Marlon H.</au><au>Torres, Marcelo D.T.</au><au>Matos, Carolina O.</au><au>Silva, Osmar N.</au><au>Lu, Timothy K.</au><au>Freire, Maurício V.</au><au>Neves, Natan C.</au><au>Gonçalves, Sónia</au><au>Lião, Luciano M.</au><au>Santos, Nuno C.</au><au>Porto, William F.</au><au>de la Fuente-Nunez, Cesar</au><au>Franco, Octavio L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative bacteria</atitle><jtitle>Biochimica et biophysica acta. Biomembranes</jtitle><addtitle>Biochim Biophys Acta Biomembr</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>1861</volume><issue>7</issue><spage>1375</spage><epage>1387</epage><pages>1375-1387</pages><issn>0005-2736</issn><eissn>1879-2642</eissn><abstract>Infections caused by Gram-negative bacteria, Escherichia coli and Pseudomonas aeruginosa foremost among them, constitute a major worldwide health problem. Bioinformatics methodologies are being used to rationally design new antimicrobial peptides, a potential alternative for treating these infections. One of the algorithms used to develop antimicrobial peptides is the Joker, which was used to design the peptide PaDBS1R6. This study evaluates the antibacterial activities of PaDBS1R6 in vitro and in vivo, characterizes the peptide interaction to target membranes, and investigates the PaDBS1R6 structure in contact with mimetic vesicles. Moreover, we demonstrate that PaDBS1R6 exhibits selective antimicrobial activity against Gram-negative bacteria. In the presence of negatively charged and zwitterionic lipids the structural arrangement of PaDBS1R6 transits from random coil to α-helix, as characterized by circular dichroism. The tertiary structure of PaDBS1R6 was determined by NMR in zwitterionic dodecylphosphocholine (DPC) micelles. In conclusion, PaDBS1R6 is a candidate for the treatment of nosocomial infections caused by Gram-negative bacteria, as template for producing other antimicrobial agents. [Display omitted] •PaDBS1R6 presented in-helix conformation when in contact with anionic lipid membranes•Antibacterial selectivity of PaDBS1R6 against Gram-negative bacteria•PaDBS1R6 was active in vivo in murine intraperitoneal and skin infection models.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>30926365</pmid><doi>10.1016/j.bbamem.2019.03.016</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-0580-0475</orcidid><orcidid>https://orcid.org/0000-0002-9398-2140</orcidid><orcidid>https://orcid.org/0000-0003-2903-4282</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0005-2736
ispartof Biochimica et biophysica acta. Biomembranes, 2019-07, Vol.1861 (7), p.1375-1387
issn 0005-2736
1879-2642
language eng
recordid cdi_proquest_miscellaneous_2200809465
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Anti-Bacterial Agents - pharmacology
Antibiotic resistance
Antimicrobial Cationic Peptides - pharmacology
Antimicrobial peptide (AMP)
Drug design
Escherichia coli
Gram-Negative Bacteria - drug effects
Joker algorithm
Mice
Mice, Inbred C57BL
Microbial Sensitivity Tests
PaDBS1R6
Pseudomonas aeruginosa
title Selective antibacterial activity of the cationic peptide PaDBS1R6 against Gram-negative bacteria
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A36%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective%20antibacterial%20activity%20of%20the%20cationic%20peptide%20PaDBS1R6%20against%20Gram-negative%20bacteria&rft.jtitle=Biochimica%20et%20biophysica%20acta.%20Biomembranes&rft.au=Fensterseifer,%20Isabel%20C.M.&rft.date=2019-07-01&rft.volume=1861&rft.issue=7&rft.spage=1375&rft.epage=1387&rft.pages=1375-1387&rft.issn=0005-2736&rft.eissn=1879-2642&rft_id=info:doi/10.1016/j.bbamem.2019.03.016&rft_dat=%3Cproquest_cross%3E2200809465%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2200809465&rft_id=info:pmid/30926365&rft_els_id=S0005273619300744&rfr_iscdi=true